Ranbaxy/GSK Partnership Yields First Drug Candidate
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy and GlaxoSmithKline have identified the first clinical candidate to be developed under their discovery alliance, the two firms announced April 2